Trinity J. Bivalacqua

I am a urologic cancer surgeon and sexual medicine specialist at the University of Pennsylvania. I run a basic translational research lab

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Comprehensive review article on adaptive immunity in GU Cancers led by @CanImmun

@tbivala1 @pcvblack @MattGalsky @ImmunoBladder @IBCG_BladderCA @IBCN1997 #bladdercancer

[Roger Li @UrogerliMD]

Long awaited data from @SWOG 1011 investigating value of ELND in MIBC
👉no diff in DFS w ELND
👉more LN yield
👉more SAE w ELND
👉? benefit in pT3/4

Congrats to Dr. Seth Lerner and the entire team 👏👏👏

#ASCO23

[Trinity J. Bivalacqua @tbivala1]

Honored to discuss @ASCO (pinch hitting for @UroDocAsh ) S1011 trial results demonstrating NO DFS/OS for EPLND @slernerbcmedu1 concludes that SLND is now standard of care for T2-T4N0 patients undergoing RC. >LN counts, >morbidity. Predominantly T2 cohort with 57%NAC!

[Andrea Apolo, M.D. @apolo_andrea]

@tbivala1 give his take home messages for the 1] #SWOGS1011 surgical trial of standard vs extended lymphadenectomy 2] the #VESPER trial of dd-MVAC vs GC as perioperative chemo for MIBC 3] #CheckMate914 Adjuvant Nivo/Ipi in high risk #RCC after nephrectomy @ASCO #ASCO23

[Gary Steinberg @garysteinbergmd]

@UrogerliMD @UroDocAsh @tbivala1 @cgoncology Outstanding combo replication selective cretostimogene plus checkpoint inhibitor Proof of principle and improving patient outcomes with very high NMIBC #gdsfellows @bcan_chisolm

[Roger Li @UrogerliMD]

Updated results from #CORE1 using pembro + cretostimogene (cg0070) in BCG unresponsive CIS

👉 Overall CR = 85% (29/34)
👉CR @ 12 months = 68% (17/25)
👉AE profile similar to monotherapy trials

@garysteinbergmd @UroDocAsh @tbivala1 @cgoncology

https://t.co/9jvfxWkzcs

[Phillip Pierorazio @drphil_urology]

The hap-hap-happiest time of the year!

The two jolliest elves this side of the nuthouse!!

[European Urology Oncology @EurUrolOncol]

Intermediate-risk Non–muscle-invasive BC: Updated Consensus Definition and Management Recommendations from the International BC Group

https://t.co/Kiu8F6sjcu

@drtanws @garysteinbergmd @UrogerliMD @DrShariat @MRoupret @tbivala1 @spsutkaMD @SWilliams_MD @uromc @UroDocAsh

[Trinity J. Bivalacqua @tbivala1]

@benchallacombe @CRCPress @ClaireJTaylor1 @Yasminabugh To all my colleagues please consider responding to @benchallacombe tweet!

[Ben Challacombe @benchallacombe]

#urotwitter What are the 50 Landmark papers urologists should know? for a new @CRCPress book. These can be a new procedure, evaluating effects of new treatments/techniques, new classification system or insights into disease. With great coauthors @ClaireJTaylor1 @Yasminabugh

[Trinity J. Bivalacqua @tbivala1]

@brady_urology @kara_lombardo @MaxKates @djmcconkey Done in @tbivala1 lab

[Trinity J. Bivalacqua @tbivala1]

@brady_urology @JHBladderCancer Done in @tbivala1 lab

[Todd 〽️ Morgan, MD @wandering_gu]

Former @brady_urology co-residents caught out in the wild 🤙 👍 #AUA22

[Trinity J. Bivalacqua @tbivala1]

Congrats to my past mentee @MeeraChappidi and current mentee @ridwanalam_ on their much deserved grants from the @UrologyCareFdn

[Max Kates @MaxKates]

@brady_urology @aloksinghjnu @8Monali Work done in the @tbivala1 lab

[Max Kates @MaxKates]

@brady_urology @aloksinghjnu @8Monali @tbivala1 https://t.co/uW2C5snRIs

[Bishai Lab @BishaiLab]

A new candidate vaccine against NMIBC in a multi institutional study in close collaboration with @tbivala1

Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against… https://t.co/wjhtgyYLVe

[Trinity J. Bivalacqua @tbivala1]

@bbmdmsk @MaxKates @MSchoenbergMD Experience, understanding of disease biology, and thoughtful strong mentorship/teaching of fellows and trainees on the technique is recipe for success. However we need more granular factors pre and intraoperAtively to make this transferable to all

[Trinity J. Bivalacqua @tbivala1]

@drphil_urology @m_e_nielsen @jimhumd @brady_urology @allaf_mo @EdwardSchaeffer @dannymak76 @gpalapa2 @LoebStacy Dr Walsh taught us to be compassionate, caring, motivated, kind physicians/scientists.We knew he was our biggest advocate/cheerleader.He taught us to mentor others through our behavior”leading by example” @SUO_YUO @UroOnc

[Sunil Patel MD @SHPatelMD1]

@MaxKates @Svet_MD @brady_urology @tbivala1 @ClaireDlc Could not agree more. These in addition to publication by @KKBree, highlighting the importance of changing the dogma in female cystectomies.